Simcyp Report issue

For profit Phase 3
Founded: Sheffield United Kingdom (2001)
Status: Acquired by Certara (2012)

Organization Overview

First Clinical Trial
2015
NCT02282176
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Simcyp Limited (SimCyp)